| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 28.15▲ | 28.11▲ | 28.11▲ | 29.84▼ | 30.29▼ |
| MA10 | 28.16▲ | 28.17▲ | 28.07▲ | 30.80▼ | 30.52▼ |
| MA20 | 27.96▲ | 28.85▼ | 29.15▼ | 31.13▼ | 33.46▼ |
| MA50 | 29.59▼ | 30.69▼ | 30.85▼ | 31.63▼ | 31.14▼ |
| MA100 | 30.83▼ | 31.14▼ | 31.25▼ | 33.73▼ | 27.28▲ |
| MA200 | 31.20▼ | 31.13▼ | 31.21▼ | 32.41▼ | 24.10▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.132▲ | 0.061▲ | 0.008▲ | -0.308▼ | -0.705▼ |
| RSI | 42.653▼ | 34.531▼ | 33.966▼ | 34.525▼ | 40.304▼ |
| STOCH | 33.010 | 68.952 | 54.760 | 30.466 | 33.803 |
| WILL %R | -49.718 | -29.431 | -68.833 | -82.962▼ | -91.074▼ |
| CCI | 0.601 | 14.342 | -28.134 | -228.174▼ | -129.946▼ |
|
Tuesday, April 14, 2026 05:27 PM
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented ...
|
|
Friday, April 10, 2026 01:22 PM
Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness efforts ~15,000 children ...
|
|
Wednesday, April 08, 2026 06:15 AM
Mesoblast’s Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/04/26 | 28.45 | 29.25 | 27.50 | 28.09 | 32,628 |
| 20/04/26 | 30.00 | 30.505 | 27.02 | 28.45 | 71,815 |
| 17/04/26 | 31.00 | 31.9999 | 30.00 | 30.29 | 60,163 |
| 16/04/26 | 31.305 | 32.3499 | 30.61 | 30.81 | 42,705 |
| 15/04/26 | 32.25 | 32.43 | 30.7201 | 31.57 | 55,605 |
| 14/04/26 | 32.38 | 32.9999 | 31.61 | 32.64 | 27,448 |
| 13/04/26 | 31.65 | 32.9229 | 30.73 | 32.38 | 25,140 |
| 10/04/26 | 31.16 | 32.44 | 30.71 | 31.17 | 71,142 |
| 09/04/26 | 31.82 | 31.98 | 30.433 | 30.81 | 105,223 |
| 08/04/26 | 32.03 | 32.3042 | 31.4601 | 31.84 | 65,700 |
|
|
||||
|
|
||||
|
|